50 related articles for article (PubMed ID: 14616155)
1. Drug interaction between infliximab and azathioprine in patients with Crohn's disease.
Roblin X; Serre-Debeauvais F; Phelip JM; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2003 Nov; 18(9):917-25. PubMed ID: 14616155
[TBL] [Abstract][Full Text] [Related]
2. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial.
Woodcock A; Vestbo J; Bakerly ND; New J; Gibson JM; McCorkindale S; Jones R; Collier S; Lay-Flurrie J; Frith L; Jacques L; Fletcher JL; Harvey C; Svedsater H; Leather D;
Lancet; 2017 Nov; 390(10109):2247-2255. PubMed ID: 28903864
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma arising from a presacral cyst in a patient with ulcerative colitis under azathioprine and infliximab: first case report.
Andrade P; Lopes S; Coelho R; Terroso G; Lage J; Macedo G
Int J Colorectal Dis; 2016 Aug; 31(8):1509-10. PubMed ID: 26857617
[No Abstract] [Full Text] [Related]
5. Anal Squamous Cell Carcinoma: An Infrequent Challenge in the Management of Ulcerative Colitis Under Combination Therapy.
Kotze PG; Zacharias P;
J Crohns Colitis; 2016 May; 10(5):626-7. PubMed ID: 26818664
[No Abstract] [Full Text] [Related]
6. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Popova V; Daly EJ; Trivedi M; Cooper K; Lane R; Lim P; Mazzucco C; Hough D; Thase ME; Shelton RC; Molero P; Vieta E; Bajbouj M; Manji H; Drevets WC; Singh JB
Am J Psychiatry; 2019 Jun; 176(6):428-438. PubMed ID: 31109201
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis.
Jiyad Z; Olsen CM; Burke MT; Isbel NM; Green AC
Am J Transplant; 2016 Dec; 16(12):3490-3503. PubMed ID: 27163483
[TBL] [Abstract][Full Text] [Related]
8. A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma.
Scheinfeld N
Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656278
[TBL] [Abstract][Full Text] [Related]
9. [A case of squamous cell carcinoma of the breast in a patient with Crohn's disease taking azathioprine].
Park KC; Ju DU; Heo SW; Ryu JI; Cho JY; Kim EJ; Oh HK; Kim EY
Korean J Gastroenterol; 2012 Dec; 60(6):373-6. PubMed ID: 23242021
[TBL] [Abstract][Full Text] [Related]
10. Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: case report and review of the literature.
Vilas-Boas F; Magro F; Balhau R; Lopes JM; Beça F; Eloy C; Lopes S; Macedo G
J Crohns Colitis; 2012 Aug; 6(7):792-5. PubMed ID: 22464812
[TBL] [Abstract][Full Text] [Related]
11. Safety of infliximab in 10 years of clinical practice.
O'Donnell S; Murphy S; Anwar MM; O'Sullivan M; Breslin N; O'Connor HJ; Ryan BM; O'Morain CA
Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):603-6. PubMed ID: 21602689
[TBL] [Abstract][Full Text] [Related]
12. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.
Long MD; Herfarth HH; Pipkin CA; Porter CQ; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2010 Mar; 8(3):268-74. PubMed ID: 20005977
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.
Chen SC; Cummings OW; Hartley MP; Filomena CA; Cho WK
Dig Dis Sci; 2006 May; 51(5):952-5. PubMed ID: 16670938
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine and UVA light generate mutagenic oxidative DNA damage.
O'Donovan P; Perrett CM; Zhang X; Montaner B; Xu YZ; Harwood CA; McGregor JM; Walker SL; Hanaoka F; Karran P
Science; 2005 Sep; 309(5742):1871-4. PubMed ID: 16166520
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
16. Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review.
Mallick B; Malik S
Cureus; 2022 May; 14(5):e24874. PubMed ID: 35698683
[TBL] [Abstract][Full Text] [Related]
17. Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn's disease and ulcerative colitis.
Hashash JG; Fadel CGA; Rimmani HH; Sharara AI
Ann Gastroenterol; 2021; 34(5):612-624. PubMed ID: 34475731
[TBL] [Abstract][Full Text] [Related]
18. Optimising use of thiopurines in inflammatory bowel disease.
Raj LS; Hawthorne AB
Frontline Gastroenterol; 2010 Apr; 1(1):44-51. PubMed ID: 28839543
[TBL] [Abstract][Full Text] [Related]
19. Monitoring and safety of azathioprine therapy in inflammatory bowel disease.
Kim MJ; Choe YH
Pediatr Gastroenterol Hepatol Nutr; 2013 Jun; 16(2):65-70. PubMed ID: 24010109
[TBL] [Abstract][Full Text] [Related]
20. Alternative strategies for the use of infliximab in pediatric inflammatory bowel disease.
Rosh JR
Curr Gastroenterol Rep; 2008 Jun; 10(3):302-7. PubMed ID: 18625142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
